A Washington University research study seeks overweight participants.
The purpose of this study is to compare cardiometabolic health between metabolically-normal and metabolically abnormal obese participants.
This study will last up to 1 year. Participants will visit the research center about 8 times before randomization. The outpatient visits range from less than 1 hour to approximately 6 hours in length. There may be up to two 48-hour inpatient stays. Participants may be randomly assigned to either a Mediterranean, low-carbohydrate, or low-fat plant based diet.
There will be medical screening, blood draws, muscle and fat biopsies, sleep monitoring, ECG, DXA and MRI/MRS scans, and a weight loss intervention. Compensation is provided for time and effort. Risks and benefits will be discussed as part of the informed consent process (IRB ID #: 201908237).
For more information
|Clinical Study Identifier||TX142521|
|Last Modified on||23 November 2020|
Select a piece of text and start making personal notes.
You have contacted , on
Your message has been sent to the study team at ,
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.Learn more
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.Learn more
Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.Learn more
Congrats! You have your own personal workspace now.